First successful case of platinum-based chemotherapy for neuroendocrine prostate cancer with BRCA2 and PTEN alterations.
IJU Case Rep
; 5(1): 41-44, 2022 Jan.
Article
in En
| MEDLINE
| ID: mdl-35005470
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
IJU Case Rep
Year:
2022
Document type:
Article